Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.
The author has received a research grant from Johnson and Johnson.
BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics
Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas
We want your feedback. Do these subject areas make sense for this article? If not, click the flag
next to the incorrect subject area and we will review it. Thanks for your help!
Ambra 2.9.1 Managed Colocation provided by Internet Systems Consortium.
Send us feedback